Bristol-Myers Squibb (BMY)
$66.68
0.66 (1.00%)
BMY Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
108.99B
PE Ratio
116.98
EPS
0.57
Volume (Avg. Vol.)
4.95M
Day's Range
65.54 - 66.86
52-Week Range
45.76 - 68.34
Dividend & Yield
1.60 (2.40%)
BMY Stock Predictions, Articles, and Bristol-Myers Squibb News
M&A News: MyoKardia (MYOK) Stock Soars on Bristol Myers Squibb Deal
MyoKardia's major, $13.1 billon deal with fellow pharmaceutical company Bristol Myers Squibb sent MYOK stock soaring on Monday.
This Company is the Landlord of Life Sciences
Alexandria Real Estate Equities is the largest landlord in the US for laboratories and related offices.
5 Top Stock Trades for Friday: UBER, FB, BMY, MU, TWLO
Bristol-Myers Squibb, Uber, Facebook, Micron and Twilio were our top stock trades for Friday. That said, let's look at the charts now.
Bristol-Myers Squibb Earnings: BMY Stock Jumps 2% on Q2 Beats
Bristol-Myers Squibb earnings on Thursday have BMY stock rising higher after the company beat EPS and revenue estimates from Wall Street.
Bristol-Myers Squibb Is a Dirt-Cheap Buy Before Earnings
Thanks to its Celgene acquisition, Bristol-Myers Squibb looks attractive ahead of earnings. Here's why you should buy BMY stock.
Bristol-Myers Squibb Has Great Potential Ahead of Earnings
Ahead earnings, Bristol-Myers Squibb is a great value play. In fact, BMY stock is worth 30%-70% more than its current share price.
Undervalued Bristol-Myers Squibb Stock Is Worth 50% More
BMY stock looks cheap here. Bristol-Myers is a defensive value with an attractive yield, cheap valuation, and plenty of potential upside.
3 Big Stock Charts for Friday: Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline
Friday's big stock charts feature pharmaceutical-market names that recently posted terrific earnings data.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
